FIELD: organic chemistry, medicine, oncology. SUBSTANCE: invention relates to the use of derivatives of 2-hydroxy-5-phenylazobenzoic acid for chemoprophylaxis and chemotherapy of patients with colon cancer. EFFECT: enhanced effectiveness of treatment, decreased adverse effects. 9 cl, 4 tbl, 8 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND COMPOSITION FOR PERORAL INTAKE OF TAXANES BY A PATIENT | 1998 |
|
RU2205005C2 |
| COMPOSITION AND METHODS FOR TREATMENT OR PROPHYLAXIS OF INFLAMMATORY DISEASES | 1997 |
|
RU2242974C2 |
| APPLICATION OF SINGLE DOSE OF CD20-SPECIFIC BINDING MOLECULES | 2006 |
|
RU2421242C2 |
| 4- OR 5-AMINOSALICYLIC ACID DERIVATIVES | 2006 |
|
RU2414476C2 |
| METHOD OF TREATING INTESTINAL DISEASES | 2009 |
|
RU2519649C2 |
| PREPARATION BASED ON MIXTURE OF FLAVONOIDS WITH FREE B-CYCLE AND FLAVANES, AS THERAPEUTIC AGENT | 2006 |
|
RU2411941C2 |
| AGENT FOR PROPHYLAXIS AND/OR TREATMENT OF UNDESIRED INFLAMMATION ACTIVITY AND CANCER PROPHYLAXIS | 2000 |
|
RU2279282C2 |
| THERAPY OF INTESTINAL ADENOMA AND/OR ADENOCARCINOMA BY INHIBITING NOTCH ACTIVATION | 2005 |
|
RU2392961C2 |
| PHOSPHORAMIDATE ALKYLATOR PRODRUG | 2006 |
|
RU2414475C2 |
| GASTROINTESTINAL PROLIFERATIVE FACTOR AND ITS APPLICATIONS | 2005 |
|
RU2343158C2 |
Authors
Dates
2001-01-10—Published
1995-01-06—Filed